Vistagen Therapeutics (VTGN) Price to Sales (2012 - 2026)
Vistagen Therapeutics' (VTGN) Price to Sales came in at 6.01 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 96.9% from 194.46 a year earlier but up 47.3% from the prior quarter.
Vistagen Therapeutics (VTGN) Price to Sales (2012 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Price to Sales stood at 18.43, down 87.7% from FY2025.
- In prior fiscal years, Vistagen Therapeutics' Price to Sales was 149.99 in FY2025 (+56.2%), 96.04 in FY2024 (-23.1%), 124.85 in FY2023 (-46.0%) and 231.10 in FY2022 (+37.2%).
- Quarterly Price to Sales has run from a low of 4.08 in fiscal Q1 2027 to a high of 266.48 in fiscal Q3 2022 over five years.
- On a year-over-year basis, Price to Sales has declined in each of the last four quarters, with an average decline of 25.5% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was fiscal Q1 2025, with growth of 931.2%; the weakest was fiscal Q2 2027, with a decline of 96.9%.
- According to Business Quant data, Price to Sales for the three prior fiscal quarters was 4.08 (Q1 2027), 18.42 (Q4 2026) and 33.10 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.01 |
| Jun 30, 2026 | 4.08 |
| Mar 31, 2026 | 18.42 |
| Dec 31, 2025 | 33.10 |
| Sep 30, 2025 | 194.46 |
| Jun 30, 2025 | 94.99 |
| Mar 31, 2025 | 149.99 |
| Dec 31, 2024 | 128.03 |
| Sep 30, 2024 | 99.54 |
| Jun 30, 2024 | 98.18 |
| Mar 31, 2024 | 95.06 |
| Dec 31, 2023 | 127.79 |
| Sep 30, 2023 | 61.48 |
| Jun 30, 2023 | 9.52 |
| Mar 31, 2023 | 18.18 |
| Dec 31, 2022 | 14.56 |
| Sep 30, 2022 | 19.40 |
| Jun 30, 2022 | 170.91 |
| Mar 31, 2022 | 231.10 |
| Dec 31, 2021 | 260.94 |
Vistagen Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();